EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploration of the Tertiary Amide Chemical Space of Dolastatin 15 Analogs Reveals New Insights into the Structure–Anticancer Activity Relationship

Dayana Alonso iD, Leslie Reguera iD, Robert Rennert iD, Ibrahim Morgan, Mohammed Saoud, Manuel G Ricardo, Leslie Valdés, Julieta Coro-Bermello iD, Ludger A Wessjohann iD, Daniel G Rivera iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Dayana Alonso und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, D-06120, Halle (Saale), Germany. Hauptthemen laut MEDLINE: Antineoplastic Agents, Amides, Depsipeptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DAAD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dolastatins are a class of naturally occurring antimitotic peptides that have inspired the development of some of the most active and widely used anticancer agents. Here, we report on the development of synthetic methodologies for the preparation of parallel libraries of small peptides inspired by dolastatin 15 and its analogs cemadotin and tasidotin. The approaches rely on the use of either one or multiple Ugi‐multicomponent reactions to generate amide N ‐substituted dolastatin‐like skeletons, which allow the exploration of tertiary amide chemical spaces that have not been assessed previously. Evaluation of the anticancer activity in a variety of cancer cells showed that introducing a tertiary amide at the C ‐terminal fragment or by replacement of a proline residue does not lead to an increment in the anti‐proliferative activity. The microtubule‐disrupting capacity of the new dolastatin analogs was studied and compared with other potent antimitotic agents, thereby shedding light on mechanistic details of their anti‐proliferative activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAmidesDepsipeptidesHumansStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorCell Line, TumorDose-Response Relationship, DrugMolecular Structure

Stichwörter der Autor:innen

anticancer compoundsdolastatinsmulticomponent reactionspeptidessolid‐phase synthesis

Substanzen

Antineoplastic AgentsAmidesDepsipeptides

Autor:innen und Institutionen

  • Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, D-06120, Halle (Saale), Germany.
  • Laboratory of Synthetic and Biomolecular Chemistry, Faculty of Chemistry, University of Havana, Zapata & G, Havana, 10400, Cuba.
  • Institute of Pharmacy and Food Chemistry, University of Havana, 222 Street.Nr.2317, Havana, 10600, Cuba.

ORCID-Profile: Dayana Alonso, Leslie Reguera, Robert Rennert, Julieta Coro-Bermello, Ludger A Wessjohann, Daniel G Rivera

Förderung

  • DAAD

Zitieren

APA

Alonso, D., Reguera, L., Rennert, R., Morgan, I., Saoud, M., Ricardo, M. G., Valdés, L., Coro-Bermello, J., Wessjohann, L. A., & Rivera, D. G. (2025). Exploration of the Tertiary Amide Chemical Space of Dolastatin 15 Analogs Reveals New Insights into the Structure–Anticancer Activity Relationship. ChemMedChem. https://doi.org/10.1002/cmdc.202500580

Vancouver

Alonso D, Reguera L, Rennert R, Morgan I, Saoud M, Ricardo MG, et al. Exploration of the Tertiary Amide Chemical Space of Dolastatin 15 Analogs Reveals New Insights into the Structure–Anticancer Activity Relationship. ChemMedChem. 2025. doi:10.1002/cmdc.202500580

BibTeX
@article{Alonso2025,
  author = {Alonso, Dayana and Reguera, Leslie and Rennert, Robert and Morgan, Ibrahim and Saoud, Mohammed and Ricardo, Manuel G and Valdés, Leslie and Coro-Bermello, Julieta and Wessjohann, Ludger A and Rivera, Daniel G},
  title = {Exploration of the Tertiary Amide Chemical Space of Dolastatin 15 Analogs Reveals New Insights into the Structure–Anticancer Activity Relationship},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500580}
}
Kostenlos starten →